|
市場調査レポート
商品コード
1386578
間葉系幹細胞市場レポート:2030年までの動向、予測、競合分析Mesenchymal Stem Cell Market Report: Trends, Forecast and Competitive Analysis to 2030 |
||||||
カスタマイズ可能
適宜更新あり
|
間葉系幹細胞市場レポート:2030年までの動向、予測、競合分析 |
出版日: 2023年10月12日
発行: Lucintel
ページ情報: 英文 150 Pages
納期: 3営業日
|
間葉系幹細胞の動向と予測
世界の間葉系幹細胞市場は、2024年から2030年までのCAGRが13.1%で、2030年までに推定66億米ドルに達すると予想されています。この市場の主な促進要因は、糖尿病、がん、自己免疫疾患などの慢性疾患の罹患率の上昇、再生医療の魅力の高まり、間葉系幹細胞を利用した革新的な治療法の創出を目指すバイオ製薬企業の研究開発努力の急増です。間葉系幹細胞の世界市場の将来は、疾患モデリング、創薬開発、幹細胞バンキング、組織工学、毒性研究市場において有望です。
間葉系幹細胞市場の洞察
Lucintelは、同種間葉系幹細胞の臨床使用における強い安全性の実績が注目され、同種間葉系幹細胞の移植は、免疫反応を誘発する可能性が低く、免疫抑制特性があるため、画期的な細胞ベースの治療法になると予測しています。
間葉系幹細胞は、生命を脅かす様々な疾患に対する潜在的な治療オプションとして、その有効性と安全性を評価することを目的とした臨床試験が米国内で現在進行中であるため、予測期間中、北米が最大の地域であることに変わりはないと思われます。
Mesenchymal Stem Cell Trends and Forecast
The future of the global mesenchymal stem cell market looks promising with opportunities in the disease modelling, drug development & discovery, stem cell banking, tissue engineering, and toxicology study markets. The global mesenchymal stem cell market is expected to reach an estimated $6.6 billion by 2030 with a CAGR of 13.1% from 2024 to 2030. The major drivers for this market are rising incidence of chronic conditions including diabetes, cancer, and autoimmune illnesses, growing appeal of regenerative medicine, and surge in research and development efforts by biopharmaceutical firms to create innovative therapies utilizing mesenchymal stem cells.
A more than 150-page report is developed to help in your business decisions.
Mesenchymal Stem Cell by Segment
The study includes a forecast for the global mesenchymal stem cell by workflow, type, application, and region.
Mesenchymal Stem Cell Market by Workflow [Shipment Analysis by Value from 2018 to 2030]:
Mesenchymal Stem Cell Market by Type [Shipment Analysis by Value from 2018 to 2030]:
Mesenchymal Stem Cell Market by Application [Shipment Analysis by Value from 2018 to 2030]:
Mesenchymal Stem Cell Market by Region [Shipment Analysis by Value from 2018 to 2030]:
List of Mesenchymal Stem Cell Companies
Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies mesenchymal stem cell companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the mesenchymal stem cell companies profiled in this report include-
Mesenchymal Stem Cell Market Insights
Lucintel forecasts that allogeneic will remain the larger segment over the forecast period due to strong safety track record of allogeneic mesenchymal stem cells in clinical use is noteworthy, and transplantation of allogeneic MSCs is poised to become a groundbreaking cell-based therapeutic method owing to its low potential for triggering immune responses and its immunosuppressive properties.
North America will remain the largest region over the forecast period because the significant volume of clinical trials is currently in progress within the United States, aimed at evaluating the effectiveness and safety of mesenchymal stem cells as a potential treatment option for various life-threatening diseases.
Features of the Global Mesenchymal Stem Cell Market
Market Size Estimates: Mesenchymal stem cell market size estimation in terms of value ($B).
Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.
Segmentation Analysis: Mesenchymal stem cell market size by workflow, type, application, and region in terms of value ($B).
Regional Analysis: Mesenchymal stem cell market breakdown by North America, Europe, Asia Pacific, and Rest of the World.
Growth Opportunities: Analysis of growth opportunities in different workflow, type, application, and regions for the mesenchymal stem cell market.
Strategic Analysis: This includes M&A, new product development, and competitive landscape of the mesenchymal stem cell market.
Analysis of competitive intensity of the industry based on Porter's Five Forces model.
FAQ
Q.1 What is the mesenchymal stem cell market size?
Answer: The global mesenchymal stem cell market is expected to reach an estimated $6.6 billion by 2030.
Q.2 What is the growth forecast for mesenchymal stem cell market?
Answer: The global mesenchymal stem cell market is expected to grow with a CAGR of 13.1% from 2024 to 2030.
Q.3 What are the major drivers influencing the growth of the mesenchymal stem cell market?
Answer: The major drivers for this market are rising incidence of chronic conditions including diabetes, cancer, and autoimmune illnesses, growing appeal of regenerative medicine, and surge in research and development efforts by biopharmaceutical firms to create innovative therapies utilizing mesenchymal stem cells.
Q4. What are the major segments for mesenchymal stem cell market?
Answer: The future of the global mesenchymal stem cell market looks promising with opportunities in the disease modelling, drug development & discovery, stem cell banking, tissue engineering, and toxicology study markets.
Q5. Who are the key mesenchymal stem cell market companies?
Answer: Some of the key mesenchymal stem cell companies are as follows:
Q6. Which mesenchymal stem cell market segment will be the largest in future?
Answer: Lucintel forecasts that allogeneic will remain the larger segment over the forecast period due to strong safety track record of allogeneic mesenchymal stem cells in clinical use is noteworthy, and transplantation of allogeneic MSCs is poised to become a groundbreaking cell-based therapeutic method owing to its low potential for triggering immune responses and its immunosuppressive properties.
Q7. In mesenchymal stem cell market, which region is expected to be the largest in next 5 years?
Answer: North America will remain the largest region over the forecast period because the significant volume of clinical trials is currently in progress within the United States, aimed at evaluating the effectiveness and safety of mesenchymal stem cells as a potential treatment option for various life-threatening diseases.
Q.8 Do we receive customization in this report?
Answer: Yes, Lucintel provides 10% customization without any additional cost.